VIRAL COAGULATION: Pushing the Envelope.

Many virus types affect the blood clotting system with correlations to pathology that range widely from thrombosis to haemorrhage linking to inflammation. Here we overview the intricate crosstalk induced by infection between proteins on the virus encoded by either the host or virus genomes, coagulation proteins, platelets, leukocytes, and endothelial cells. For blood-borne viruses with an outer covering acquired from the host cell, the envelope, a key player may be the cell-derived trigger of coagulation on the virus surface, tissue factor (TF). TF is a multifunctional transmembrane cofactor that accelerates factor (F) VIIa-dependent activation of FX to FXa leading to clot formation. However, the nascent TF/FVIIa/FXa complex also facilitates G-protein-coupled modulation of cells via protease activated receptor-2. As a viral envelope constituent, TF can bypass the physiological modes of regulation, thereby initiating the activation of neighbouring platelets leukocytes and endothelial cells. A thromboinflammatory environment is predicted due to feedback amplification in response to cellular release of cytokines, procoagulant proteins and neutrophil extracellular traps, and stimulus-induced accessibility of adhesive receptors resulting in cellular aggregates. The pathobiological effects of thromboinflammation ultimately contribute to innate and adaptive immunity for viral clearance. In contrast, the preceding stages of viral infection may be enhanced via the TF-protease axis.